Multidimensional cardiometabolic protection with SGLT2 inhibitors and GLP-1 receptor agonists in obesity, type 2 diabetes and hypertension
Obesity Medicine · 2026-07 · 62 · 100719
DOI: 10.1016/j.obmed.2026.100719 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity Medicine, 2026-07. Verfasst von Renu Vajjiravelu und 4 weiteren Autor:innen. Die Arbeit nennt 99 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Vajjiravelu, R., Kirtheka, P., Palani, B., Jayakodi, S., & Kirubakaran, D. (2026). Multidimensional cardiometabolic protection with SGLT2 inhibitors and GLP-1 receptor agonists in obesity, type 2 diabetes and hypertension. Obesity Medicine, 62, 100719. https://doi.org/10.1016/j.obmed.2026.100719
Vancouver
Vajjiravelu R, Kirtheka P, Palani B, Jayakodi S, Kirubakaran D. Multidimensional cardiometabolic protection with SGLT2 inhibitors and GLP-1 receptor agonists in obesity, type 2 diabetes and hypertension. Obesity Medicine. 2026;62:100719. doi:10.1016/j.obmed.2026.100719
BibTeX
@article{Vajjiravelu2026,
author = {Vajjiravelu, Renu and Kirtheka, P.S. and Palani, Banuppriya and Jayakodi, Santhoshkumar and Kirubakaran, Dharmalingam},
title = {Multidimensional cardiometabolic protection with SGLT2 inhibitors and GLP-1 receptor agonists in obesity, type 2 diabetes and hypertension},
journal = {Obesity Medicine},
year = {2026},
volume = {62},
pages = {100719},
doi = {10.1016/j.obmed.2026.100719}
}
EUVIMED